These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 20395096

  • 1. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study.
    Banerjee B, Sharma U, Balasubramanian K, Kalaivani M, Kalra V, Jagannathan NR.
    Magn Reson Imaging; 2010 Jun; 28(5):698-707. PubMed ID: 20395096
    [Abstract] [Full Text] [Related]

  • 2. Creatine but not betaine supplementation increases muscle phosphorylcreatine content and strength performance.
    del Favero S, Roschel H, Artioli G, Ugrinowitsch C, Tricoli V, Costa A, Barroso R, Negrelli AL, Otaduy MC, da Costa Leite C, Lancha-Junior AH, Gualano B.
    Amino Acids; 2012 Jun; 42(6):2299-305. PubMed ID: 21744011
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of creatine supplementation in dystrophic patients.
    Louis M, Lebacq J, Poortmans JR, Belpaire-Dethiou MC, Devogelaer JP, Van Hecke P, Goubel F, Francaux M.
    Muscle Nerve; 2003 May; 27(5):604-10. PubMed ID: 12707981
    [Abstract] [Full Text] [Related]

  • 4. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.
    Tarnopolsky M, Mahoney D, Thompson T, Naylor H, Doherty TJ.
    Muscle Nerve; 2004 Jan; 29(1):51-8. PubMed ID: 14694498
    [Abstract] [Full Text] [Related]

  • 5. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.
    Kemp GJ, Meyerspeer M, Moser E.
    NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042
    [Abstract] [Full Text] [Related]

  • 6. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
    Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, Tesi-Rocha C, Gorni K, Pasquali L, Patel KM, McCarter R, Huang J, Mayhew T, Bertorini T, Carlo J, Connolly AM, Clemens PR, Goemans N, Iannaccone ST, Igarashi M, Nevo Y, Pestronk A, Subramony SH, Vedanarayanan VV, Wessel H, CINRG Group.
    Ann Neurol; 2005 Jul; 58(1):151-5. PubMed ID: 15984021
    [Abstract] [Full Text] [Related]

  • 7. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study.
    Khushu S, Rana P, Sekhri T, Sripathy G, Tripathi RP.
    Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062
    [Abstract] [Full Text] [Related]

  • 8. Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy.
    Hsieh TJ, Jaw TS, Chuang HY, Jong YJ, Liu GC, Li CW.
    J Comput Assist Tomogr; 2009 Jun; 33(1):150-4. PubMed ID: 19188804
    [Abstract] [Full Text] [Related]

  • 9. Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy.
    McCully K, Giger U, Argov Z, Valentine B, Cooper B, Chance B, Bank W.
    Muscle Nerve; 1991 Nov; 14(11):1091-8. PubMed ID: 1745283
    [Abstract] [Full Text] [Related]

  • 10. Metabolic disturbances during short exercises in dermatomyositis revealed by real-time functional 31P magnetic resonance spectroscopy.
    Pfleiderer B, Lange J, Loske KD, Sunderkötter C.
    Rheumatology (Oxford); 2004 Jun; 43(6):696-703. PubMed ID: 15054156
    [Abstract] [Full Text] [Related]

  • 11. In vivo (31)P MRS study of skeletal muscle metabolism in patients with postpolio residual paralysis.
    Sharma U, Kumar V, Wadhwa S, Jagannathan NR.
    Magn Reson Imaging; 2007 Feb; 25(2):244-9. PubMed ID: 17275621
    [Abstract] [Full Text] [Related]

  • 12. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study.
    Kornblum C, Schröder R, Müller K, Vorgerd M, Eggers J, Bogdanow M, Papassotiropoulos A, Fabian K, Klockgether T, Zange J.
    Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of creatine supplementation in knee osteoarthritis.
    Neves M, Gualano B, Roschel H, Fuller R, Benatti FB, Pinto AL, Lima FR, Pereira RM, Lancha AH, Bonfá E.
    Med Sci Sports Exerc; 2011 Aug; 43(8):1538-43. PubMed ID: 21311365
    [Abstract] [Full Text] [Related]

  • 14. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
    Dewhirst MW, Poulson JM, Yu D, Sanders L, Lora-Michiels M, Vujaskovic Z, Jones EL, Samulski TV, Powers BE, Brizel DM, Prosnitz LR, Charles HC.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):480-91. PubMed ID: 15667971
    [Abstract] [Full Text] [Related]

  • 15. Effects of creatine supplementation on the onset of neuromuscular fatigue threshold and muscle strength in elderly men and women (64 - 86 years).
    Stout JR, Sue Graves B, Cramer JT, Goldstein ER, Costa PB, Smith AE, Walter AA.
    J Nutr Health Aging; 2007 Feb 01; 11(6):459-64. PubMed ID: 17985060
    [Abstract] [Full Text] [Related]

  • 16. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK, Kong SW, Sung SM, Hirashima F, Parow A, Hennen J, Cohen BM, Renshaw PF.
    Psychiatry Res; 2003 Jun 30; 123(2):87-100. PubMed ID: 12850248
    [Abstract] [Full Text] [Related]

  • 17. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study.
    Felber S, Skladal D, Wyss M, Kremser C, Koller A, Sperl W.
    Neurol Res; 2000 Mar 30; 22(2):145-50. PubMed ID: 10763500
    [Abstract] [Full Text] [Related]

  • 18. Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up.
    Hooijmans MT, Doorenweerd N, Baligand C, Verschuuren JJGM, Ronen I, Niks EH, Webb AG, Kan HE.
    PLoS One; 2017 Mar 30; 12(8):e0182086. PubMed ID: 28763477
    [Abstract] [Full Text] [Related]

  • 19. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S, Li LM, Costallat LT, Cendes F.
    Brain; 2005 Dec 30; 128(Pt 12):2933-40. PubMed ID: 16195241
    [Abstract] [Full Text] [Related]

  • 20. Effect of creatine and weight training on muscle creatine and performance in vegetarians.
    Burke DG, Chilibeck PD, Parise G, Candow DG, Mahoney D, Tarnopolsky M.
    Med Sci Sports Exerc; 2003 Nov 30; 35(11):1946-55. PubMed ID: 14600563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.